Analyst Ratings for PTC Therapeutics (PTCT)
PTCT Rating Summary
PTCT Price Target Summary
- Highest: $200.00 (Rosenblatt)
- Lowest: $54.00 (Leerink)
- Average: $96.12
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$96.12 (+21.7%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 76%
Avg. $ Target:
$96.12 (+21.7%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 76%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/9/2026 | Citi | Eric Joseph | Upgrade | Buy (Neutral) |
108.00 (75.00) |
70.87 (78.98) |
11.44% | Details |
| 5/27/2026 | Jefferies | Faisal Khurshid | Upgrade | Buy (Hold) |
85.00 (76.00) |
67.65 (78.98) |
16.75% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
